Regulation of the cyclin-dependent kinase inhibitor 1A gene (CDKN1A) by the repressor BOZF1 through inhibition of p53 acetylation and transcription factor Sp1 binding

Journal of Biological Chemistry

Volumn 288, Issue 10, 2013, Pages 7053-7064

  Kim, Min Kyeong ^a   Jeon, Bu Nam ^a   Koh, Dong In ^a   Kim, Kyung Sup ^a   Park, So Yoon ^b   Yun, Chae Ok ^c   Hur, Man Wook ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Soonchunhyang University   (South Korea)

^c Hanyang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE; CYCLIN-DEPENDENT KINASE INHIBITORS; NEGATIVE REGULATORS; ONCOGENESIS; P53 AND P21; TUMOR SUPPRESSION; TUMOR SUPPRESSORS;

ACETYLATION; CELL PROLIFERATION; TRANSCRIPTION FACTORS; TUMORS;

TRANSCRIPTION;

BTB POZ AND ZINC FINGER DOMAIN FACTOR ON CHROMOSOME 1 PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; E1A ASSOCIATED P300 PROTEIN; MESSENGER RNA; PROTEIN P21; PROTEIN P53; REGULATOR PROTEIN; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG;

ACETYLATION; ANIMAL TISSUE; ARTICLE; BTB POZ AND ZINC FINGER DOMAIN FACTOR ON CHROMOSOME 1 GENE; CELL PROLIFERATION; CONTROLLED STUDY; CYCLIN DEPENDENT KINASE INHIBITOR 1A GENE; DNA BASE COMPOSITION; DNA BINDING; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INTERACTION; GENE REPRESSION; GENETIC STABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; P21 GENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REGULATOR GENE; TRANSCRIPTION FACTOR SP1 GENE; TUMOR SUPPRESSOR GENE;

ACETYLATION; ANIMALS; BINDING SITES; BINDING, COMPETITIVE; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; GENE EXPRESSION REGULATION; HCT116 CELLS; HEK293 CELLS; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MICE; NIH 3T3 CELLS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SP1 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84874889705     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.416297     Document Type: Article

References (46)

1. Costoya, J. A. (2007) Functional analysis of the role of POK transcriptional repressors. Brief. Funct. Genomic. Proteomic. 6, 8-18 (Pubitemid 351721044)
2. Kelly, K. F., and Daniel, J. M. (2006) POZ for effect-POZ-ZF transcription factors in cancer and development. Trends Cell Biol. 16, 578-587 (Pubitemid 44636217)
3. Ye, B. H., Lista, F., Lo Coco, F., Knowles, D. M., Offit, K., Chaganti, R. S., and Dalla-Favera, R. (1993) Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma. Science 262, 747-750 (Pubitemid 23350695)
4. Kerckaert, J. P., Deweindt, C., Tilly, H., Quief, S., Lecocq, G., and Bastard, C. (1993) LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas. Nat. Genet. 5, 66-70 (Pubitemid 23261521)
5. Chen, Z., Brand, N. J., Chen, A., Chen, S. J., Tong, J. H., Wang, Z. Y., Waxman, S., and Zelent, A. (1993) Fusion between a novel Krüppel-like zinc finger gene and the retinoic acid receptor-γ locus due to a variant t(11;17) translocation associated with acute promyelocytic leukaemia. EMBO J. 12, 1161-1167 (Pubitemid 23095865)
6. Melnick, A., Ahmad, K. F., Arai, S., Polinger, A., Ball, H., Borden, K. L., Carlile, G. W., Prive, G. G., and Licht, J. D. (2000) In-depth mutational analysis of the promyelocytic leukemia zinc finger BTB/POZ domain reveals motifs and residues required for biological and transcriptional functions. Mol. Cell. Biol. 20, 6550-6567 (Pubitemid 30650240)
7. Pessler, F., Pendergrast, P. S., and Hernandez, N. (1997) Purification and characterization of FBI-1, a cellular factor that binds to the human immunodeficiency virus type 1 inducer of short transcripts. Mol. Cell. Biol. 17, 3786-3798 (Pubitemid 27281853)
8. Lee, D. K., Suh, D., Edenberg, H. J., and Hur, M. W. (2002) POZ domain transcription factor, FBI-1, represses transcription of ADH5/FDH by interacting with the zinc finger and interfering withDNAbinding activity of Sp1. J. Biol. Chem. 277, 26761-26768 (Pubitemid 34951680)
9. Maeda, T., Hobbs, R. M., Merghoub, T., Guernah, I., Zelent, A., Cordon-Cardo, C., Teruya-Feldstein, J., and Pandolfi, P. P. (2005) Role of the protooncogene Pokemon in cellular transformation and ARF repression. Nature 433, 278-285
10. Fujii, H., Biel, M. A., Zhou, W., Weitzman, S. A., Baylin, S. B., and Gabrielson, E. (1998) Methylation of the HIC-1 candidate tumor suppressor gene in human breast cancer. Oncogene 16, 2159-2164 (Pubitemid 28211691)
11. Wales, M. M., Biel, M. A., el Deiry, W., Nelkin, B. D., Issa, J. P., Cavenee, W. K., Kuerbitz, S. J., and Baylin, S. B. (1995) p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3. Nat. Med. 1, 570-577
12. Peukert, K., Staller, P., Schneider, A., Carmichael, G., Hänel, F., and Eilers, M. (1997) An alternative pathway for gene regulation by Myc.EMBOJ. 16, 5672-5686 (Pubitemid 27399859)
13. Schneider, A., Peukert, K., Eilers, M., and Hänel, F. (1997) Association of Myc with the zinc-finger protein Miz-1 defines a novel pathway for gene regulation by Myc. Curr. Top. Microbiol. Immunol. 224, 137-146 (Pubitemid 27368550)
14. Phan, R. T., Saito, M., Basso, K., Niu, H., and Dalla-Favera, R. (2005) BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells. Nat. Immunol. 6, 1054-1060 (Pubitemid 41486191)
15. Yeyati, P. L., Shaknovich, R., Boterashvili, S., Li, J., Ball, H. J., Waxman, S., Nason-Burchenal, K., Dmitrovsky, E., Zelent, A., and Licht, J. D. (1999) Leukemia translocation protein PLZF inhibits cell growth and expression of cyclin A. Oncogene 18, 925-934 (Pubitemid 29086269)
16. Choi, W. I., Jeon, B. N., Yun, C. O., Kim, P. H., Kim, S. E., Choi, K. Y., Kim, S. H., and Hur, M. W. (2009) Proto-oncogene FBI-1 represses transcription of p21CIP1 by inhibition of transcription activation by p53 and Sp1. J. Biol. Chem. 284, 12633-12644
17. Weber, A., Marquardt, J., Elzi, D., Forster, N., Starke, S., Glaum, A., Yamada, D., Defossez, P. A., Delrow, J., Eisenman, R. N., Christiansen, H., and Eilers, M. (2008) Zbtb4 represses transcription of P21CIP1 and controls the cellular response to p53 activation. EMBO J. 27, 1563-1574 (Pubitemid 351794031)
18. Prives, C., and Hall, P. A. (1999) The p53 pathway. J. Pathol. 187, 112-126 (Pubitemid 29009841)
19. King, K. L., and Cidlowski, J. A. (1998) Cell cycle regulation and apoptosis. Annu. Rev. Physiol. 60, 601-617 (Pubitemid 28157888)
20. Lane, D. P. (1992) Cancer. p53, guardian of the genome. Nature 358, 15-16
21. Evan, G. I., and Vousden, K. H. (2001) Proliferation, cell cycle and apoptosis in cancer. Nature 411, 342-348 (Pubitemid 32467043)
22. Bode, A. M., and Dong, Z. (2004) Post-translational modification of p53 in tumorigenesis. Nat. Rev. Cancer 4, 793-805 (Pubitemid 39331151)
23. Olsson, A., Manzl, C., Strasser, A., and Villunger, A. (2007) How important are post-translational modifications in p53 for selectivity in targetgene transcription and tumour suppression? Cell Death Differ. 14, 1561-1575 (Pubitemid 47278842)
24. el-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825 (Pubitemid 23346378)
25. McKenzie, P. P., Guichard, S. M., Middlemas, D. S., Ashmun, R. A., Danks, M. K., and Harris, L. C. (1999) Wild-type p53 can induce p21 and apoptosis in neuroblastoma cells but the DNA damage-induced G1 checkpoint function is attenuated. Clin. Cancer Res. 5, 4199-4207 (Pubitemid 30013806)
26. Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., and Vogelstein, B. (1998) Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282, 1497-1501 (Pubitemid 28538613)
27. Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K., and Elledge, S. J. (1993) The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75, 805-816 (Pubitemid 23346377)
28. van den Heuvel, S., and Harlow, E. (1993) Distinct roles for cyclin-dependent kinases in cell cycle control. Science 262, 2050-2054 (Pubitemid 24041887)
29. Waldman, T., Kinzler, K. W., and Vogelstein, B. (1995) p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res. 55, 5187-5190
30. Gartel, A. L., and Tyner, A. L. (1999) Transcriptional regulation of the p21WAF1/CIP1 gene. Exp. Cell Res. 246, 280-289
31. Gartel, A. L., Goufman, E., Najmabadi, F., and Tyner, A. L. (2000) Sp1 and Sp3 activate p21WAF1/CIP1 gene transcription in the Caco-2 colon adenocarcinoma cell line. Oncogene 19, 5182-5188
32. Koutsodontis, G., Tentes, I., Papakosta, P., Moustakas, A., and Kardassis, D. (2001) Sp1 plays a critical role in the transcriptional activation of the human cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by the p53 tumor suppressor protein. J. Biol. Chem. 276, 29116-29125
33. Canman, C. E., Lim, D. S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M. B., and Siliciano, J. D. (1998) Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281, 1677-1679 (Pubitemid 28435584)
34. Tibbetts, R. S., Brumbaugh, K. M., Williams, J. M., Sarkaria, J. N., Cliby, W. A., Shieh, S. Y., Taya, Y., Prives, C., and Abraham, R. T. (1999) A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev. 13, 152-157 (Pubitemid 29061945)
35. Ito, A., Lai, C. H., Zhao, X., Saito, S., Hamilton, M. H., Appella, E., and Yao, T. P. (2001) p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2. EMBO J. 20, 1331-1340 (Pubitemid 32233973)
36. Tang, Y., Luo, J., Zhang, W., and Gu, W. (2006) Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis. Mol. Cell 24, 827-839 (Pubitemid 44960094)
37. Liu, L., Scolnick, D. M., Trievel, R. C., Zhang, H. B., Marmorstein, R., Halazonetis, T. D., and Berger, S. L. (1999) p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage. Mol. Cell. Biol. 19, 1202-1209 (Pubitemid 29046862)
38. Luo, J., Li, M., Tang, Y., Laszkowska, M., Roeder, R. G., and Gu, W. (2004) Acetylation of p53 augments its site-specific DNA binding both in vitro and in vivo. Proc. Natl. Acad. Sci. U.S.A. 101, 2259-2264 (Pubitemid 38269299)
39. Zhao, Y., Lu, S., Wu, L., Chai, G., Wang, H., Chen, Y., Sun, J., Yu, Y., Zhou, W., Zheng, Q., Wu, M., Otterson, G. A., and Zhu, W. G. (2006) Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21(Waf1/Cip1). Mol. Cell. Biol. 26, 2782-2790
40. Chao, C., Wu, Z., Mazur, S. J., Borges, H., Rossi, M., Lin, T., Wang, J. Y., Anderson, C. W., Appella, E., and Xu, Y. (2006) Acetylation of mouse p53 at lysine 317 negatively regulates p53 apoptotic activities after DNA damage. Mol. Cell. Biol. 26, 6859-6869 (Pubitemid 44387635)
41. Luo, J., Nikolaev, A. Y., Imai, S., Chen, D., Su, F., Shiloh, A., Guarente, L., and Gu, W. (2001) Negative control of p53 by Sir2-promotes cell survival under stress. Cell 107, 137-148 (Pubitemid 33035941)
42. Luo, J., Su, F., Chen, D., Shiloh, A., and Gu, W. (2000) Deacetylation of p53 modulates its effect on cell growth and apoptosis. Nature 408, 377-381
43. Jeon, B. N., Choi, W. I., Yu, M. Y., Yoon, A. R., Kim, M. H., Yun, C. O., and Hur, M. W. (2009) ZBTB2, a novel master regulator of the p53 pathway. J. Biol. Chem. 284, 17935-17946
44. Lee, K. M., Choi, W. I., Koh, D. I., Kim, Y. J., Jeon, B. N., Yoon, J. H., Lee, C. E., Kim, S. H., Oh, J., and Hur, M. W. (2012) The proto-oncoprotein KR-POK represses transcriptional activation of CDKN1A by MIZ-1 through competitive binding. Oncogene 31, 1442-1458
45. Jeon, B. N., Kim, M. K., Choi, W. I., Koh, D. I., Hong, S. Y., Kim, K. S., Kim, M., Yun, C. O., Yoon, J., Choi, K. Y., Lee, K. R., Nephew, K. P., and Hur, M. W. (2012) KR-POK interacts with p53 and represses its ability to activate transcription of p21WAF1/CDKN1A. Cancer Res. 72, 1137-1148
46. Koh, D. I., Choi, W. I., Jeon, B. N., Lee, C. E., Yun, C. O., and Hur, M. W. (2009) A novel POK family transcription factor, ZBTB5, represses transcription of p21CIP1 gene. J. Biol. Chem. 284, 19856-19866